XML 55 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Revenues $ 88,647 $ 80,490 $ 173,591 $ 157,148
Net investment income (loss) 274 146 608 314
Total revenues 88,921 80,636 174,199 157,462
Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 55,062 51,326 107,847 98,816
Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 5,629 5,736 11,226 11,049
Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 25,108 21,260 49,460 42,891
Other        
Disaggregation of Revenue [Line Items]        
Revenues 2,848 2,168 5,058 4,392
Operating Segments | Health Care Benefits        
Disaggregation of Revenue [Line Items]        
Revenues 26,521 22,633 52,213 45,618
Net investment income (loss) 205 88 369 177
Total revenues 26,747 22,741 52,624 45,835
Operating Segments | Health Care Benefits | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Care Benefits | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Care Benefits | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 25,095 21,245 49,434 42,859
Operating Segments | Health Care Benefits | Other        
Disaggregation of Revenue [Line Items]        
Revenues 1,447 1,408 2,821 2,799
Operating Segments | Health Services        
Disaggregation of Revenue [Line Items]        
Revenues 43,032 39,946 83,843 76,257
Net investment income (loss) 0 0 0 0
Total revenues 46,215 42,938 90,806 82,553
Operating Segments | Health Services | Pharmacy network        
Disaggregation of Revenue [Line Items]        
Total revenues 27,477 25,896 55,069 50,024
Operating Segments | Health Services | Mail & specialty        
Disaggregation of Revenue [Line Items]        
Total revenues 17,229 16,283 33,374 30,951
Operating Segments | Health Services | Other        
Disaggregation of Revenue [Line Items]        
Total revenues 1,509 759 2,363 1,578
Operating Segments | Health Services | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 44,706 42,179 88,443 80,975
Operating Segments | Health Services | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Services | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Health Services | Other        
Disaggregation of Revenue [Line Items]        
Revenues 1,509 759 2,363 1,578
Operating Segments | Pharmacy & Consumer Wellness        
Disaggregation of Revenue [Line Items]        
Revenues 19,079 17,877 37,505 35,208
Net investment income (loss) 1 (18) (2) (34)
Total revenues 28,784 26,746 56,706 52,644
Operating Segments | Pharmacy & Consumer Wellness | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 22,614 20,442 44,394 40,412
Operating Segments | Pharmacy & Consumer Wellness | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 5,629 5,736 11,226 11,049
Operating Segments | Pharmacy & Consumer Wellness | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Operating Segments | Pharmacy & Consumer Wellness | Other        
Disaggregation of Revenue [Line Items]        
Revenues 540 586 1,088 1,217
Corporate/ Other        
Disaggregation of Revenue [Line Items]        
Revenues 15 34 30 65
Net investment income (loss) 68 76 241 171
Total revenues 83 110 271 236
Corporate/ Other | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Corporate/ Other | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Corporate/ Other | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 13 15 26 32
Corporate/ Other | Other        
Disaggregation of Revenue [Line Items]        
Revenues 2 19 4 33
Intersegment Eliminations        
Disaggregation of Revenue [Line Items]        
Net investment income (loss) 0 0 0 0
Total revenues (12,908) (11,899) (26,208) (23,806)
Intersegment Eliminations | Pharmacy        
Disaggregation of Revenue [Line Items]        
Revenues (12,258) (11,295) (24,990) (22,571)
Intersegment Eliminations | Front Store        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Intersegment Eliminations | Premiums        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Intersegment Eliminations | Other        
Disaggregation of Revenue [Line Items]        
Revenues $ (650) $ (604) $ (1,218) $ (1,235)